Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

67.12USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$67.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,264,517
52-wk High
$88.16
52-wk Low
$64.25

Kaelin, William 

Dr. William G. Kaelin Jr., M.D., is Independent Director of Eli Lilly and Co. He is a prominent medical researcher and academician. He has extensive experience at Harvard Medical School, a major medical institution, as well as special expertise in oncology—a key component of Lilly's business. He also has deep expertise in basic science, including mechanisms of drug action, and experience with pharmaceutical discovery research.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

16,562,500

Derica Rice

6,935,410

Maria Crowe

--

Jan Lundberg

6,778,350

Melissa Barnes

--

Michael Harrington

4,780,500
As Of  30 Dec 2015